XML 44 R33.htm IDEA: XBRL DOCUMENT v3.19.1
STOCKHOLDERS' EQUITY AND SHARE-BASED COMPENSATION (Details)
3 Months Ended
Mar. 31, 2019
USD ($)
$ / shares
shares
Stockholders' equity:  
Number of options outstanding, beginning | shares 2,067,500
Number of options granted | shares 1,000,000
Number of options exercised | shares 0
Number of options forfeited/cancelled | shares 0
Number of options outstanding, ending | shares 3,067,500
Number of options vested and exercisable | shares 225,000
Weighted average exercise price outstanding, beginning $ 1.68
Weighted average exercise price granted 5.41
Weighted average exercise price exercised 0
Weighted average exercise price forfeited/cancelled 0
Weighted average exercise price outstanding, ending 2.9
Weighted average exercise price vested and exercisable $ 1.5
Weighted average remaining contractual term granted 5 years
Weighted average remaining contractual term outstanding, ending 4 years 5 months 12 days
Weighted average remaining contractual term vested and exercisable 4 years 1 month 24 days
Aggregate intrinsic value outstanding, beginning | $ $ 3,063,375
Aggregate intrinsic value granted $ 0
Aggregate intrinsic value exercised | $ $ 0
Aggregate intrinsic value forfeited/cancelled $ 0
Aggregate intrinsic value outstanding, ending | $ $ 12,887,800
Aggregate intrinsic value vested and exercisable | $ $ 1,260,000